AnaptysBio, Inc. (ANAB)

NASDAQ: ANAB · Real-Time Price · USD

56.69

-2.57 (-4.34%)

At close: Aug 20, 2026, 4:00 PM EDT

57.71

+1.02 (1.80%)

Pre-market: Aug 21, 2026, 5:01 AM EDT

AnaptysBio Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	232.39	234.6	91.28	17.16	10.29	63.18
Revenue Growth	107.73%	157.01%	432.03%	66.78%	-83.72%	-15.77%
Gross Profit	103.61	98.63	-72.56	-115.13	-78.51	-35.32
Operating Income	40.8	47.9	-114.95	-157.07	-115.15	-56.81
Net Income	-26.79	-13.23	-145.23	-163.62	-128.72	-57.8
Earnings Per Share	-0.95	-0.46	-5.12	-6.08	-4.57	-2.11
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	286.46	311.64	385.37	390.9	441.24	548.1
Total Debt	277.36	290.64	369.46	328.62	323.86	272.05
Net Cash (Debt)	9.1	21	15.91	62.28	117.38	276.05
Net Cash Growth	-	31.98%	-74.45%	-46.94%	-57.48%	-29.81%
Net Cash Per Share	0.32	0.73	0.56	2.31	4.17	10.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.48	19.7	-135.34	-120.8	-73.59	-45.92
Capital Expenditures	-0.07	-0.09	-0.36	-0.81	-0.36	-1.37
Free Cash Flow	4.41	19.61	-135.7	-121.61	-73.95	-47.29
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	44.58%	42.04%	-79.49%	-	-	-55.91%
Operating Margin	17.56%	20.42%	-125.93%	-915.50%	-1119.41%	-89.93%
Pretax Margin	-11.46%	-5.57%	-159.10%	-953.68%	-1251.09%	-91.49%
Profit Margin	-11.53%	-5.64%	-159.11%	-953.66%	-1251.33%	-91.49%
FCF Margin	1.90%	8.36%	-148.66%	-708.79%	-718.88%	-74.85%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	31.83	14.68	14.68	14.68	14.68	16.86
P/FCF Ratio	380.70	68.45	-	-	-	-
PS Ratio	7.22	5.72	4.41	33.18	85.65	15.21